Table 5. Angiographic data and management strategies of ischemic cardiomyopathy subgroup of non-obese and obese NVCM patients.
Variable | Non-obese ICM 281 (45%) | Obese ICM 145 (23%) | P-value |
LM disease, N (%) | 19 (6.8%) | 9 (6.2%) | 0.840 |
LAD disease, N (%) | 169 (60%) | 68 (47%) | 0.008 |
LCX disease, N (%) | 109 (39%) | 32 (22%) | 0.000 |
RCA disease, N (%) | 110 (39%) | 39 (27%) | 0.006 |
MVD, N (%) | 135 (48%) | 48 (33%) | 0.001 |
Medical treatment, N (%) | 56 (20%) | 74 (51%) | 0.008 |
PCI/PTCA, N (%) | 138 (49%) | 41 (28%) | |
CABG, N (%) | 87 (31%) | 31 (21%) |